3, 900 Enroll Into Ebola Natural History Survivors Study, As PREVAIL Vaccine Outreach Enters Worhn In Margibi County

Mr. Bartholomew Of Prevail

At least 3,900 persons have now enrolled into the Ebola Natural History Study being conducted by PREVAIL. PREVAIL is the Partnership for Research on Ebola Virus in Liberia.

The number include 1,000 Ebola Survivors and 2,000 of their Close Contacts, people who took care of the survivors at the time they came down with Ebola.

The disclosure was made Wednesday by the Social Mobilization Manager of PREVAIL Mr. Bartholomew Wilson during a community engagement in Worhn, the administrative Headquarters of Gibi District Margibi County which was heavily hit by Ebola during the health crisis in Liberia.

Worhn Residents

The community engagement meetings organized by the Liberia Crusaders for Peace in collaboration with PREVAIL are meant to rally the support of Liberians towards the scientific research being conducted by the joint US-Liberia Clinical research partnership.

PREVAIL has launched the second phase of its vaccine study aimed at finding a potential vaccine that will help the rest of the world to prevent Ebola in the years to come.

According to Mr. Wilson unlike the first phase, children will be allowed to participate in this current vaccine study because when it is approved, the vaccine will be available to everyone.

He said though the vaccine has been proven effective, the current study will also determine how long the vaccine will stay in people who have taken it.

He then encouraged Liberians Particularly the people of Worhn in Margibi to make history for themselves by participating in the ongoing Ebola Vaccine Research study being conducted at the Redemption Hospital in the Borough of New Kru Town.

Mr. Wilson said other vaccines and medication “we take today” were all born out of similar research studies conducted in other countries before the final and approved products reached Liberia.

Residents Of Worhn

He told the well attended and elaborate community engagement meeting that the ongoing research study being conducted by the Partnership for Research on Ebola Virus in Liberia is a reinforcement of previous vaccine study successfully conducted at the Redemption Hospital in 2015.

The daylong community engagement meeting brought together a cross section of community leaders, youth, elders, religious leaders, Ebola survivors and their closed contacts and health workers in support of the PREVAIL Vaccine Study in Worhn, Margibi County on Wednesday.

Meanwhile the people of Worhn have welcomed the PREVAIL vaccine study noting that it is in the best interest of the Country and its people.

Speaking at the gathering, the residents said they appreciate any initiative that will help prevent Ebola because they don’t want to suffer the deadly effect of the virus which wrecked their communities particularly in Gibi District, Margibi County during the Ebola crisis.

Their views were echoed by the local government authorities in the area headed by Commissioner Amos Z. Boyer who pledged to give the local authorities fullest support to any initiative aimed at promoting the PREVAIL vaccine study and other research works being conducted by the joint US-Liberia clinical research partnership.

Contributed by Francis Pelenah, Jr.

(Visited 187 times, 1 visits today)
About Cholo Brooks 13211 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.